Effectiveness of rivastigmine in Alzheimer's disease - Participation in trials should be based on clinical uncertainty, not enforcement

被引:7
作者
Bullock, R [1 ]
Passmore, P
Wilkinson, D
Howard, R
Jones, R
机构
[1] Victoria Hosp, Kinghill Res Ctr, Swindon SN1 4JU, Wilts, England
[2] Queens Univ Belfast, Belfast BT9 7BL, Antrim, North Ireland
[3] Moorgreen Hosp, Thornhill Res Ctr, Southampton SO30 3JB, Hants, England
[4] Inst Psychiat, London SE5 8AF, England
[5] St Martins Hosp, Res Inst Care Elderly, Bath BA2 5RP, Avon, England
关键词
D O I
10.1136/bmj.320.7233.511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:511 / 512
页数:2
相关论文
共 5 条
  • [1] Effectiveness of rivastigmine in Alzheimer's disease - Improvements in functional ability remain unestablished
    Bentham, P
    Gray, R
    Sellwood, E
    Raftery, J
    [J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7210) : 640 - 641
  • [2] Assessment of activities of daily living in dementia: Development of the Bristol activities of daily living scale
    Bucks, RS
    Ashworth, DL
    Wilcock, GK
    Siegfried, K
    [J]. AGE AND AGEING, 1996, 25 (02) : 113 - 120
  • [3] Collins R, 1992, INTRO NEW TREATMENTS, P49
  • [4] Personal paper - New drug treatment for Alzheimer's disease: lessons for healthcare policy
    Melzer, D
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7133): : 762 - 764
  • [5] ASSESSING PATIENT DEPENDENCE IN ALZHEIMERS-DISEASE
    STERN, Y
    ALBERT, SM
    SANO, M
    RICHARDS, M
    MILLER, L
    FOLSTEIN, M
    ALBERT, M
    BYLSMA, FW
    LAFLECHE, G
    [J]. JOURNALS OF GERONTOLOGY, 1994, 49 (05): : M216 - M222